Bintayan, Norie .
HRN: 22-70-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/14/2023
03/21/2023
IV
500mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes